Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP558393.RAgFxsjofUsRk4z4Q-i6fgCDOQAwIITWYOos3AyDrEDC4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP558393.RAgFxsjofUsRk4z4Q-i6fgCDOQAwIITWYOos3AyDrEDC4130_assertion type Assertion NP558393.RAgFxsjofUsRk4z4Q-i6fgCDOQAwIITWYOos3AyDrEDC4130_head.
- NP558393.RAgFxsjofUsRk4z4Q-i6fgCDOQAwIITWYOos3AyDrEDC4130_assertion wasGeneratedBy ECO_0000203 NP558393.RAgFxsjofUsRk4z4Q-i6fgCDOQAwIITWYOos3AyDrEDC4130_provenance.
- NP558393.RAgFxsjofUsRk4z4Q-i6fgCDOQAwIITWYOos3AyDrEDC4130_assertion wasDerivedFrom befree-20140225 NP558393.RAgFxsjofUsRk4z4Q-i6fgCDOQAwIITWYOos3AyDrEDC4130_provenance.
- NP558393.RAgFxsjofUsRk4z4Q-i6fgCDOQAwIITWYOos3AyDrEDC4130_assertion SIO_000772 17164332 NP558393.RAgFxsjofUsRk4z4Q-i6fgCDOQAwIITWYOos3AyDrEDC4130_provenance.
- NP558393.RAgFxsjofUsRk4z4Q-i6fgCDOQAwIITWYOos3AyDrEDC4130_assertion evidence source_evidence_literature NP558393.RAgFxsjofUsRk4z4Q-i6fgCDOQAwIITWYOos3AyDrEDC4130_provenance.
- NP558393.RAgFxsjofUsRk4z4Q-i6fgCDOQAwIITWYOos3AyDrEDC4130_assertion description "[We show that pazopanib is the first-in-class VEGF receptor inhibitor to inhibit in vivo tumor cell growth associated with increased MM cell apoptosis, decreased angiogenesis, and prolonged survival in a mouse xenograft model of human MM.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP558393.RAgFxsjofUsRk4z4Q-i6fgCDOQAwIITWYOos3AyDrEDC4130_provenance.